Nithya Prasannan

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Recurrent thrombocytopenia in immune thrombotic thrombocytopenic purpura during the caplacizumab era.

Recurrent thrombocytopenia in immune thrombotic thrombocytopenic purpura during the caplacizumab era.

Journal: British journal of haematology
Published: March 25, 2026

Delayed ADAMTS13 normalisation in caplacizumab/PEX treated patients associated with anti-ADAMTS13 IgG antibody boosting.

Delayed ADAMTS13 normalisation in caplacizumab/PEX treated patients associated with anti-ADAMTS13 IgG antibody boosting.

Journal: Blood advances
Published: January 09, 2026

Delayed ADAMTS13 normalization in caplacizumab/PEX-treated patients associated with anti-ADAMTS13 IgG antibody boosting.

Delayed ADAMTS13 normalization in caplacizumab/PEX-treated patients associated with anti-ADAMTS13 IgG antibody boosting.

Journal: Blood advances
Published: January 09, 2026

Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpura.

Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpura.

Journal: Blood
Published: November 27, 2023

Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab era.

Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab era.

Journal: Blood
Published: October 27, 2022

The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura.

The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura.

Journal: British journal of haematology
Published: February 10, 2022

Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis.

Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis.

Journal: Blood advances
Published: December 29, 2021

Novel antiplatelet strategies targeting VWF and GPIb.

Novel antiplatelet strategies targeting VWF and GPIb.

Journal: Platelets
Published: July 03, 2020
Showing 1-8 of 8

Last Updated: 09/26/2026